By Taylor Mixides (Drug Target Review)2023-09-01T16:45:39
The field of cell therapy has emerged as a beacon of hope, promising transformative treatments for various diseases. Diving into the intricacies of this domain, this exclusive interview explores the distinctions between two key approaches – autologous and allogeneic cell therapies. We look at the nuances of cell sourcing, preclinical ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2024-02-08T11:07:39
Sponsored by Samplix ApS
2023-01-06T16:37:30
Sponsored by Catalent
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-03-28T11:38:32
Sponsored by Bio-Techne
2023-07-04T10:05:58
Sponsored by Revvity
Site powered by Webvision Cloud